Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model.

MLA

Christensen, Neil D., et al. “Formulation of Cidofovir Improves the Anti-Papillomaviral Activity of Topical Treatments in the CRPV/Rabbit Model.” Antiviral Research, vol. 108, Aug. 2014, pp. 148–55. EBSCOhost, https://doi.org/10.1016/j.antiviral.2014.06.001.

APA

Christensen, N. D., Cladel, N. M., Hu, J., & Balogh, K. K. (2014). Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV/rabbit model. Antiviral Research, 108, 148–155. https://doi.org/10.1016/j.antiviral.2014.06.001

Chicago

Christensen, Neil D, Nancy M Cladel, Jiafen Hu, and Karla K Balogh. 2014. “Formulation of Cidofovir Improves the Anti-Papillomaviral Activity of Topical Treatments in the CRPV/Rabbit Model.” Antiviral Research 108 (August): 148–55. doi:10.1016/j.antiviral.2014.06.001.